FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Magnus Vrethem

Research Profile

Disorders

Chemicals & Drugs

Co-author Network

Publications

TOP 3
H Tedeholm; Magnus Vrethem; Charlotte Dahle; J Fagius; Sten Fredrikson; Jan Hillert; Anne-Marie Landtblom; V Lisovskaja; Jan Lycke; Clas Malmeström; C Martin; O Nerman; F Piehl; Björn Runmarker; B Skoog; Leszek Stawiarz; Oluf Andersen
Time to secondary progression in patients with multiple sclerosis who were treated with first generation immunomodulating drugs.
M Kvarnström; Magnus Vrethem; J Ydrefors; Christina Ekerfelt; Jan Ernerudh
Longitudinal interferon-β effects in multiple sclerosis: differential regulation of IL-10 and IL-17A, while no sustained effects on IFN-γ, IL-4 or IL-13.
Magnus Vrethem; J Lindh; B Persson; Martin Tondel; Charlotte Dahle
IgA antibodies against tissue transglutaminase, endomysium and gliadin in idiopathic polyneuropathy.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Magnus Vrethem (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: H Tedeholm; Magnus Vrethem; Charlotte Dahle; J Fagius; Sten Fredrikson; Jan Hillert; Anne-Marie Landtblom; V Lisovskaja; Jan Lycke; Clas Malmeström; C Martin; O Nerman; F Piehl; Björn Runmarker; B Skoog; Leszek Stawiarz; Oluf Andersen
Time to secondary progression in patients with multiple sclerosis who were treated with first generation immunomodulating drugs.
Multiple sclerosis (Houndmills, Basingstoke, England) 2013;19(6):765-74.
2013: M Kvarnström; Magnus Vrethem; J Ydrefors; Christina Ekerfelt; Jan Ernerudh
Longitudinal interferon-β effects in multiple sclerosis: differential regulation of IL-10 and IL-17A, while no sustained effects on IFN-γ, IL-4 or IL-13.
Journal of the neurological sciences 2013;325(1-2):79-85.
2013: Magnus Vrethem; J Lindh; B Persson; Martin Tondel; Charlotte Dahle
IgA antibodies against tissue transglutaminase, endomysium and gliadin in idiopathic polyneuropathy.
Acta neurologica Scandinavica 2013;127(2):109-15.
2012: Magnus Vrethem; Kristina Malmgren; Jonas Lindh
A patient with both narcolepsy and multiple sclerosis in association with Pandemrix vaccination.
Journal of the neurological sciences 2012;321(1-2):89-91.
2012: Barbro Hedin Skogman; Magnus Vrethem; Lars Ödkvist; Kajsa Glimåker; Maria Nordwall; Pia Forsberg
Long-term clinical outcome after Lyme neuroborreliosis in childhood.
Pediatrics 2012;130(2):262-9.
2012: Martin Samuelsson; George Gerdin; Karin Ollinger; Magnus Vrethem
Taurine and glutathione levels in plasma before and after ECT treatment.
Psychiatry research 2012;198(1):53-7.
2012: Magnus Vrethem; A M Landtblom; P Cassel; M Gustafsson; M Kvarnström; J Stenstam; Jan Ernerudh
Cytokine mapping in cerebrospinal fluid and blood in multiple sclerosis patients without oligoclonal bands.
Multiple sclerosis (Houndmills, Basingstoke, England) 2012;18(5):669-73.
2012: Johan Mellergård; Bob Olsson; Anders Tisell; Kaj Blennow; Ida Blystad; Charlotte Dahle; Olof Dahlqvist Leinhard; Jan Ernerudh; Anne-Marie Landtblom; Peter Lundberg; Magnus Vrethem
Association between change in normal appearing white matter metabolites and intrathecal inflammation in natalizumab-treated multiple sclerosis.
PloS one 2012;7(9):e44739.
2012: István Gáti; Cecilia Gunnarsson; Bo Häggqvist; O Danielsson; Bengt-Arne Fredriksson; Magnus Vrethem; Anne-Marie Landtblom
Bent spine syndrome: a phenotype of dysferlinopathy or a symptomatic DYSF gene mutation carrier.
European neurology 2012;67(5):300-2.
2011: Magnus Vrethem; Charlotte Dahle; Björn Lindvall
Subacute neuronopathy in a young man: a possible association with tetracycline treatment.
Neurology international 2011;3(3):e16.
2011: Jonas Lindh; Bodil Persson; Peter Söderkvist; Martin Tondel; Mats Fredrikson; Shahrzad Hosseininia; Magnus Vrethem
Polymorphisms of GSTT1, GSTM1, and EPHX genotypes in patients with cryptogenic polyneuropathy: a case-control study.
Brain and behavior 2011;1(2):135-41.
2011: Magnus Vrethem; Mona Widhe; Jan Ernerudh; Ulf Garpmo; Pia Forsberg
Clinical, diagnostic and immunological characteristics of patients with possible neuroborreliosis without intrathecal Ig-synthesis against Borrelia antigen in the cerebrospinal fluid.
Neurology international 2011;3(1):e2.
2011: Martin Gunnarsson; Clas Malmeström; Markus Axelsson; Peter Sundström; Charlotte Dahle; Magnus Vrethem; Tomas Olsson; Fredrik Piehl; Niklas Norgren; Lars Rosengren; Anders Svenningsson; Jan Lycke
Axonal damage in relapsing multiple sclerosis is markedly reduced by natalizumab.
Annals of neurology 2011;69(1):83-9.
2011: M Edström; J Mellergård; J Mjösberg; Mc Jenmalm; Magnus Vrethem; R Press; C Dahle; Jan Ernerudh
Transcriptional characteristics of CD4+ T cells in multiple sclerosis: relative lack of suppressive populations in blood.
Multiple sclerosis (Houndmills, Basingstoke, England) 2011;17(1):57-66.
2011: Jonas Lindh; Martin Tondel; Bodil Persson; Magnus Vrethem
Health-related quality of life in patients with cryptogenic polyneuropathy compared with the general population.
Disability and rehabilitation 2011;33(7):617-23.
2010: Jakob Paues; Magnus Vrethem
Fatal progressive multifocal leukoencephalopathy in a patient with non-Hodgkin lymphoma treated with rituximab.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2010;48(4):291-3.
2010: Magnus Vrethem; N Reiser; C Lauermann; Eva Svanborg
Polyneuropathy associated with IgM vs IgG monoclonal gammopathy: comparison between clinical and electrophysiological findings.
Acta neurologica Scandinavica 2010;122(1):52-7.
2010: Eva Hellqvist; M Kvarnström; Anita Söderberg; Magnus Vrethem; Jan Ernerudh; Anders Rosén
Myelin protein zero is naturally processed in the B cells of monoclonal gammopathy of undetermined significance of immunoglobulin M isotype: aberrant triggering of a patient's T cells.
Haematologica 2010;95(4):627-36.
2010: J Mellergård; M Edström; Magnus Vrethem; Jan Ernerudh; Charlotte Dahle
Natalizumab treatment in multiple sclerosis: marked decline of chemokines and cytokines in cerebrospinal fluid.
Multiple sclerosis (Houndmills, Basingstoke, England) 2010;16(2):208-17.
2009: Magnus Vrethem; Tomas Lindahl
The follow-up of patients of sixty-five years of age and younger with acute ischemic stroke and transient ischemic attacks, and elevated D-dimer levels in plasma.
Neurology international 2009;1(1):e11.
2009: Gunilla M Liedberg; Magnus Vrethem
Polyneuropathy, with and without neurogenic pain, and its impact on daily life activities--a descriptive study.
Disability and rehabilitation 2009;31(17):1402-8.
2006: E Hallin; J Mellergård; Magnus Vrethem; Jan Ernerudh; Christina Ekerfelt
In vitro Th2 deviation of myelin-specific peripheral blood lymphocytes from patients with multiple sclerosis.
Journal of neuroimmunology 2006;171(1-2):156-62.
2006: Martin Tondel; Jonas Lindh; Pia Jonsson; Magnus Vrethem; Bodil Persson
Occupational determinants of cryptogenic polyneuropathy.
Neuroepidemiology 2006;26(4):187-94.
2005: Jonas Lindh; Martin Tondel; Anders Osterberg; Magnus Vrethem
Cryptogenic polyneuropathy: clinical and neurophysiological findings.
Journal of the peripheral nervous system : JPNS 2005;10(1):31-7.
2004: Magnus Vrethem; Ingrid Fernlund; Jan Ernerudh; Sten Ohman
Prognostic value of cerebrospinal fluid IgA and IgG in multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) 2004;10(4):469-71.
2004: Mona Widhe; Sara Jarefors; Christina Ekerfelt; Magnus Vrethem; Sven Bergstrom; Pia Forsberg; Jan Ernerudh
Borrelia-specific interferon-gamma and interleukin-4 secretion in cerebrospinal fluid and blood during Lyme borreliosis in humans: association with clinical outcome.
The Journal of infectious diseases 2004;189(10):1881-91.
2004: Christina Ekerfelt; Jan Ernerudh; Pia Forsberg; A L Jonsson; Magnus Vrethem; L Arlehag; Urban Forsum
Lyme borreliosis in Sweden--diagnostic performance of five commercial Borrelia serology kits using sera from well-defined patient groups.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 2004;112(1):74-8.
2003: A Jansson; Jan Ernerudh; M Kvarnström; Christina Ekerfelt; Magnus Vrethem
Elispot assay detection of cytokine secretion in multiple sclerosis patients treated with interferon-beta1a or glatiramer acetate compared with untreated patients.
Multiple sclerosis (Houndmills, Basingstoke, England) 2003;9(5):440-5.
2003: Magnus Vrethem; E Mattsson; H Hebelka; K Leerbeck; Anders Osterberg; Anne-Marie Landtblom; B Balla; H Nilsson; M Hultgren; L Brattström; B Kågedal
Increased plasma homocysteine levels without signs of vitamin B12 deficiency in patients with multiple sclerosis assessed by blood and cerebrospinal fluid homocysteine and methylmalonic acid.
Multiple sclerosis (Houndmills, Basingstoke, England) 2003;9(3):239-45.
2002: Magnus Vrethem; L Hellblom; M Widlund; M Ahl; O Danielsson; Jan Ernerudh; Pia Forsberg
Chronic symptoms are common in patients with neuroborreliosis -- a questionnaire follow-up study.
Acta neurologica Scandinavica 2002;106(4):205-8.
2002: Mona Widhe; Mattias Grusell; Christina Ekerfelt; Magnus Vrethem; Pia Forsberg; Jan Ernerudh
Cytokines in Lyme borreliosis: lack of early tumour necrosis factor-alpha and transforming growth factor-beta1 responses are associated with chronic neuroborreliosis.
Immunology 2002;107(1):46-55.
2002: Magnus Vrethem; Jörgen Boivie; Hans Arnqvist; Helen Holmgren; Torbjörn Lindström
Painful polyneuropathy in patients with and without diabetes: clinical, neurophysiologic, and quantitative sensory characteristics.
The Clinical journal of pain 2002;18(2):122-7.
2002: M Kvarnstrom; E Sidorova; J Nilsson; Christina Ekerfelt; Magnus Vrethem; O Soderberg; M Johansson; A Rosen; Jan Ernerudh
Myelin protein P0-specific IgM producing monoclonal B cell lines were established from polyneuropathy patients with monoclonal gammopathy of undetermined significance (MGUS).
Clinical and experimental immunology 2002;127(2):255-62.
2000: Qi Cheng; Guo-Xin Jiang; Rayomand Press; M Andersson; B Ekstedt; Magnus Vrethem; L J Liedholm; H Lindsten; L Brattström; Sten Fredrikson; Hans Link; Jesús de Pedro-Cuesta
Clinical epidemiology of Guillain-Barré syndrome in adults in Sweden 1996-97: a prospective study.
European journal of neurology : the official journal of the European Federation of Neurological Societies 2000;7(6):685-92.
1999: T Masterma; Arturs Ligers; Olle Olerup; Magnus Vrethem; Jan Hillert
CTLA-4 dimorphisms in gammopathy-associated peripheral neuropathy.
European journal of neurology : the official journal of the European Federation of Neurological Societies 1999;6(4):491-3.
1999: Göran Solders; Inger Nennesmo; Jan Ernerudh; M Cruz; Magnus Vrethem
Lymphocytes in sural nerve biopsies from patients with plasma cell dyscrasia and polyneuropathy.
Journal of the peripheral nervous system : JPNS 1999;4(2):91-8.
1999: RA Elkarim; M Mustafa; Hans Link; Moiz Bakhiet; Christina Ekerfelt; Magnus Vrethem; Jan Ernerudh
Induction of neutralizing autoantibodies to interferon-gamma in patients with polyneuropathy.
Human antibodies 1999;9(1):55-60.
1998: Magnus Vrethem; Charlotte Dahle; Christina Ekerfelt; Pia Forsberg; O Danielsson; Jan Ernerudh
CD4 and CD8 lymphocyte subsets in cerebrospinal fluid and peripheral blood from patients with multiple sclerosis, meningitis and normal controls.
Acta neurologica Scandinavica 1998;97(4):215-20.
1998: K Jáuregui-Renaud; B Kovacsovics; Magnus Vrethem; L M Odjvist; Torbjörn Ledin
Dynamic and randomized perturbed posturography in the follow-up of patients with polyneuropathy.
Archives of medical research 1998;29(1):39-44.
1997: Charlotte Dahle; Christina Ekerfelt; Magnus Vrethem; M Samuelsson; Jan Ernerudh
T helper type 2 like cytokine responses to peptides from P0 and P2 myelin proteins during the recovery phase of Guillain-Barré syndrome.
Journal of the neurological sciences 1997;153(1):54-60.
1997: Magnus Vrethem; Jörgen Boivie; H Arnqvist; H Holmgren; T Lindström; L H Thorell
A comparison a amitriptyline and maprotiline in the treatment of painful polyneuropathy in diabetics and nondiabetics.
The Clinical journal of pain 1997;13(4):313-23.
1997: Christina Ekerfelt; Jan Ernerudh; J Bunikis; Magnus Vrethem; J Aagesen; M Roberg; S Bergström; Pia Forsberg
Compartmentalization of antigen specific cytokine responses to the central nervous system in CNS borreliosis: secretion of IFN-gamma predominates over IL-4 secretion in response to outer surface proteins of Lyme disease Borrelia spirochetes.
Journal of neuroimmunology 1997;79(2):155-62.
1997: Christina Ekerfelt; Jan Ernerudh; Magnus Vrethem
Th1-like responses to peptides from peripheral nerve myelin proteins in patients with polyneuropathy associated with monoclonal gammopathy.
Clinical and experimental immunology 1997;108(3):516-22.
1997: A Fogdell; Olle Olerup; Sten Fredrikson; Magnus Vrethem; Jan Hillert
Linkage analysis of HLA class II genes in Swedish multiplex families with multiple sclerosis.
Neurology 1997;48(3):758-62.
1995: Pia Forsberg; Jan Ernerudh; Christina Ekerfelt; M Roberg; Magnus Vrethem; S Bergström
The outer surface proteins of Lyme disease borrelia spirochetes stimulate T cells to secrete interferon-gamma (IFN-gamma): diagnostic and pathogenic implications.
Clinical and experimental immunology 1995;101(3):453-60.
1995: Magnus Vrethem; Christina Ekerfelt; Jan Ernerudh
Avidity distribution of antibodies against peripheral nerve myelin in patients with polyneuropathy associated with IgM monoclonal gammopathy and in healthy controls.
Journal of the neurological sciences 1995;131(2):190-9.
1995: Christina Ekerfelt; Jan Ernerudh; G Solders; Magnus Vrethem
CD5 expression on B cells may be an activation marker for secretion of anti-myelin antibodies in patients with polyneuropathy associated with monoclonal gammopathy.
Clinical and experimental immunology 1995;101(2):346-50.
1995: S Ohman; Jan Ernerudh; Pia Forsberg; M Roberg; Magnus Vrethem
Lower values for immunoglobulin M in cerebrospinal fluid when sampled with an atraumatic Sprotte needle compared with conventional lumbar puncture.
Annals of clinical biochemistry 1995;32 ( Pt 2)():210-2.
1995: Jan Ernerudh; Magnus Vrethem
[Immunomediated polyneuropathies. New discoveries on pathogenesis and treatment].
Läkartidningen 1995;92(5):378-81.
1994: Charlotte Dahle; Magnus Vrethem; Jan Ernerudh
T lymphocyte subset abnormalities in peripheral blood from patients with the Guillain-Barré syndrome.
Journal of neuroimmunology 1994;53(2):219-25.
1994: Magnus Vrethem; Charlotte Dahle; C Ekerfeldt; J Nilsson; B Ekstedt; Jan Ernerudh
Abnormalities in T-lymphocyte populations in blood from patients with demyelinating polyneuropathy associated with monoclonal gammopathy.
Journal of the neurological sciences 1994;122(2):171-8.
1994: Jan Hillert; T Käll; Magnus Vrethem; Sten Fredrikson; M Ohlson; Olle Olerup
The HLA-Dw2 haplotype segregates closely with multiple sclerosis in multiplex families.
Journal of neuroimmunology 1994;50(1):95-100.
1993: Magnus Vrethem; B Larsson; H von Schenck; Jan Ernerudh
Immunofixation superior to plasma agarose electrophoresis in detecting small M-components in patients with polyneuropathy.
Journal of the neurological sciences 1993;120(1):93-8.
1993: S Ohman; Jan Ernerudh; Pia Forsberg; H von Schenck; Magnus Vrethem
Improved formulae for the judgement of intrathecally produced IgA and IgM in the presence of blood CSF barrier damage.
Annals of clinical biochemistry 1993;30 ( Pt 5)():454-62.
1993: Magnus Vrethem; T Skogh; Jan Ernerudh; B Ekstedt; O Andersen; J Lycke
Soluble interleukin-2 receptor levels in serum of patients with demyelinating polyneuropathy associated with monoclonal gammopathy.
Journal of neurology, neurosurgery, and psychiatry 1993;56(6):721-2.
1993: Pam Fredman; J Lycke; O Andersen; Magnus Vrethem; Jan Ernerudh; Lars Svennerholm
Peripheral neuropathy associated with monoclonal IgM antibody to glycolipids with a terminal glucuronyl-3-sulfate epitope.
Journal of neurology 1993;240(6):381-7.
1993: Magnus Vrethem; Jan Ernerudh; Mabel Cruz; O Olerup; G Solders; B Ekstedt; O Andersen; Jan Hillert
Susceptibility to demyelinating polyneuropathy in plasma cell dyscrasia may be influenced by amino acid position 9 of the HLA-DR beta chain.
Journal of neuroimmunology 1993;43(1-2):139-44.
1993: Magnus Vrethem; M Cruz; H Wen-Xin; C Malm; H Holmgren; Jan Ernerudh
Clinical, neurophysiological and immunological evidence of polyneuropathy in patients with monoclonal gammopathies.
Journal of the neurological sciences 1993;114(2):193-9.
1992: Magnus Vrethem; A Henriksson; C Malm; T Olsson; Jan Ernerudh
Ig-secreting cells pass the blood-brain barrier: studies on kappa and lambda light chain secreting cells in plasma cell dyscrasia.
Journal of neuroimmunology 1992;41(2):189-94.
1992: Magnus Vrethem; Thomas Skogh; G Berlin; Jan Ernerudh
Autoantibodies versus clinical symptoms in blood donors.
The Journal of rheumatology 1992;19(12):1919-21.
1992: Jan Ernerudh; Magnus Vrethem; O Andersen; C Lindberg; G Berlin
Immunochemical and clinical effects of immunosuppressive treatment in monoclonal IgM neuropathy.
Journal of neurology, neurosurgery, and psychiatry 1992;55(10):930-4.
1992: S Ohman; Jan Ernerudh; Pia Forsberg; A Henriksson; H von Schenck; Magnus Vrethem
Comparison of seven formulae and isoelectrofocusing for determination of intrathecally produced IgG in neurological diseases.
Annals of clinical biochemistry 1992;29 ( Pt 4)():405-10.
1992: Magnus Vrethem; Jan Ernerudh; F Lindström; J E Olsson
Cerebral ischemia associated with anticardiolipin antibodies.
Acta neurologica Scandinavica 1992;85(6):412-7.
1991: Magnus Vrethem; Thomas Skogh; G Berlin; H Holmgren; Jan Ernerudh
Antibodies to peripheral nerve myelin may occur without clinical neuropathy in healthy persons.
Journal of neuroimmunology 1991;32(3):219-22.
1991: Magnus Vrethem; Torbjörn Ledin; Jan Ernerudh; Lars M Odkvist; H Holmgren; C Möller
Correlation between dynamic posturography, clinical investigation, and neurography in patients with polyneuropathy.
ORL; journal for oto-rhino-laryngology and its related specialties 1991;53(5):294-8.
1990: A Bengtsson; Jan Ernerudh; Magnus Vrethem; Thomas Skogh
Absence of autoantibodies in primary fibromyalgia.
The Journal of rheumatology 1990;17(12):1682-3.
1990: Magnus Vrethem; Jan Ernerudh; F Lindström; Thomas Skogh
Immunoglobulins within the central nervous system in primary Sjögren's syndrome.
Journal of the neurological sciences 1990;100(1-2):186-92.
1990: Magnus Vrethem; B Lindvall; H Holmgren; Karl G Henriksson; F Lindström; Jan Ernerudh
Neuropathy and myopathy in primary Sjögren's syndrome: neurophysiological, immunological and muscle biopsy results.
Acta neurologica Scandinavica 1990;82(2):126-31.
1990: Magnus Vrethem; I Johansson
Prognosis in patients with transient ischaemic attacks and minor stroke associated with a normal angiogram.
European neurology 1990;30(4):203-6.
1990: Torbjörn Ledin; Lars M Odkvist; Magnus Vrethem; C Möller
Dynamic posturography in assessment of polyneuropathic disease.
Journal of vestibular research : equilibrium & orientation 1990;1(2):123-8.
1989: S Ohman; Pia Forsberg; N Nelson; Magnus Vrethem
An improved formula for the judgement of intrathecally produced IgG in the presence of blood brain barrier damage.
Clinica chimica acta; international journal of clinical chemistry 1989;181(3):265-72.
1987: Magnus Vrethem; S Ohman; H von Schenck; Pia Forsberg; J E Olsson
Comparison of concentration of orosomucoid in serum and cerebrospinal fluid in different neurological diseases.
Acta neurologica Scandinavica 1987;75(5):328-31.